RB1 and pancreatic endocrine carcinoma: According to a previous report on poorly differentiated pancreatic NEC, the percentage of cases with p53 overexpression and Rb loss was 7/7 (100%) and 7/7 (100%), and those with TP53 and RB1 mutations were 4/7 (57%) and 5/7 (71%), respectively [20].